Your session is about to expire
← Back to Search
Other
Technology-Driven Intervention for Cognitive Impairment (CI Wizard Trial)
N/A
Recruiting
Research Sponsored by HealthPartners Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months post index visit
Awards & highlights
Summary
This trial aims to help early detect cognitive impairment with machine learning & clinical decision support tools, helping patients & caregivers with difficult decisions & improved quality of life.
Who is the study for?
This trial is for people aged 65 or older who visit a participating primary care clinic, have no prior diagnosis of cognitive impairment (CI), and show signs of CI based on specific tests. They must not have had chemotherapy for advanced cancer in the last year, be in hospice or palliative care.
What is being tested?
The study is testing a new system called CI-CDS that uses machine learning to help doctors spot early signs of dementia. It's integrated into electronic health records and aims to improve detection and management of cognitive issues.
What are the potential side effects?
Since this intervention involves technology rather than medication, traditional side effects are not applicable. However, there may be privacy concerns or potential stress related to increased monitoring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 months post index visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months post index visit
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
CI Diagnosis
Secondary study objectives
Clinician Confidence
Healthcare Utilization Costs
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CI-CDSExperimental Treatment1 Intervention
In clinics randomized to the CI-CDS, the providers will be given the option to use the CI-CDS tool during eligible patient encounters.
Group II: Usual Care (UC)Active Control1 Intervention
In clinics randomized to UC, patients will receive usual care at their primary care visits over the accrual period (no intervention will be given).
Find a Location
Who is running the clinical trial?
HealthPartners InstituteLead Sponsor
191 Previous Clinical Trials
3,718,656 Total Patients Enrolled
8 Trials studying Dementia
3,482 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,052,002 Total Patients Enrolled
281 Trials studying Dementia
23,626,020 Patients Enrolled for Dementia
OCHIN, Inc.OTHER
22 Previous Clinical Trials
8,722,124 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cancer is at stage 4.I am enrolled in a hospice or palliative care program.I am 65 years old or older.I have had chemotherapy through injection or IV in the past year.
Research Study Groups:
This trial has the following groups:- Group 1: CI-CDS
- Group 2: Usual Care (UC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger